Fabomotizole hydrochloride is primarily used in the field of pharmacology as an anxiolytic and stress-protective agent. It is commonly prescribed for the treatment of anxiety disorders, helping to reduce symptoms such as excessive worry, tension, and restlessness. The compound is also utilized to improve stress resistance, particularly in individuals exposed to high-stress environments or conditions. Additionally, it has shown potential in enhancing cognitive functions, such as memory and attention, making it beneficial for patients with mild cognitive impairments. Its neuroprotective properties are being explored for potential applications in managing neurodegenerative diseases. Overall, it is valued for its ability to provide therapeutic effects with a relatively low risk of side effects compared to traditional anxiolytics. As a research reagent, it is employed in studies investigating its mechanisms and applications in neuroscience and psychiatry.